| http://www.w3.org/ns/prov#value | - Zhang et al., [7] demonstrated that PPAR activator rosiglitazone inhibited human hepatocarcinoma BEL-7404 cell migration via up-regulating PTEN. The tumour suppressor gene PTEN encodes a dual-specificity phosphatase that recognizes protein and phosphatidylinositiol substrates and modulates cellular functions such as migration and proliferation.
|
